Search results
ImmunoGen (IMGN) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo News· 7 months agoFrom a technical perspective, ImmunoGen (IMGN) is looking like an interesting pick, as it just...
Should You Buy ImmunoGen (IMGN) After Golden Cross?
Zacks via Yahoo News· 1 year agoAfter reaching an important support level, ImmunoGen, Inc. (IMGN) could be a good stock pick from a technical perspective. IMGN recently experienced a...
Wall Street Analysts Think ImmunoGen (IMGN) Could Surge 49.11%: Read This Before Placing a Bet
Zacks via Yahoo News· 9 months agoThe mean of analysts' price targets for ImmunoGen (IMGN) points to a 49.1% upside in the stock....
ImmunoGen (IMGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo News· 7 months agoWhile the top- and bottom-line numbers for ImmunoGen (IMGN) give a sense of how the business...
Zacks.com featured highlights include Confluent, Pinterest, ICON and ImmunoGen
Zacks via Yahoo News· 8 months agoFor Immediate Release Chicago, IL – November 8, 2023 – Stocks in this week’s article are Confluent...
ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat
Zacks via Yahoo News· 11 months agoImmunoGen's (IMGN) Q2 earnings show an encouraging adoption of the sole-marketed drug Elahere. The...
ImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives Revenues
Zacks via Yahoo News· 8 months agoImmunoGen's (IMGN) third-quarter 2023 earnings and revenues surpass estimates, driven by strong...
ImmunoGen (IMGN) Q3 Earnings and Revenues Top Estimates
Zacks via Yahoo News· 8 months agoImmunoGen (IMGN) delivered earnings and revenue surprises of 400% and 6.02%, respectively, for the...
Here's Why You Should Add ImmunoGen (IMGN) to Your Portfolio Now
Zacks via Yahoo News· 1 year agoImmunoGen's (IMGN) recently launched drug, Elahere, is expected to generate incremental revenues for...
ImmunoGen (IMGN) Stock Surges 230% in a Month: Here's Why
Zacks via Yahoo News· 1 year agoImmunoGen (IMGN) shares surge exponentially in the past month owing to the positive data on the...